If at first you don't succeed, try moving the goal posts? Chelsea Therapeutics (CHTP) intends to...

|About: Chelsea Therapeuti... (CHTP)|By:, SA News Editor

If at first you don't succeed, try moving the goal posts? Chelsea Therapeutics (CHTPintends to modify a Phase 3 study of Northera, an experimental drug for neurogenic orthostatic hypotension. This follows previously failed studies of the drug, and the FDA will almost certainly be highly skeptical of a mid-study change in endpoints. The stock is down more than 15% on the news.